Home › Companies › STANDARD BIOTOOLS INC. › 2024-2025

STANDARD BIOTOOLS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and STANDARD BIOTOOLS INC.’s Form 8-K, filed 2025-06-20 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 138Asset managers
  • 742Fund votes
  • 2025-06-18Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore STANDARD BIOTOOLS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by STANDARD BIOTOOLS INC.

These tallies are STANDARD BIOTOOLS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

STANDARD BIOTOOLS INC. — official shareholder meeting results, meeting held 2025-06-18
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Kathy Hibbs 235,917,851---- 9,416,47081,530,196 Majority: yes
Elect Director: Frank Witney, Ph.D. 240,269,516---- 5,064,80581,530,196 Majority: yes
Proposal 2: Advisory Vote on Approval of Executive Compensation. 241,143,5344,006,163184,624 --81,530,196 Majority: yes
Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm. 322,915,2813,650,720298,516 ---- Majority: yes
Proposal 4: Approval of the Amendment to the Amended and Restated 2011 Equity Incentive Plan, as Amended. 223,394,56319,589,9732,349,785 --81,530,196 Majority: yes

Source: STANDARD BIOTOOLS INC., Form 8-K, filed with the SEC on 2025-06-20 — read the filing on EDGAR.

How asset managers voted at the STANDARD BIOTOOLS INC. 2024-2025 meeting

Each item below shows how the 138 asset managers that disclosed a STANDARD BIOTOOLS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 241,143,534AGAINST: 4,006,163

STANDARD BIOTOOLS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Approval of Executive Compensation.”): 241,143,534 for, 4,006,163 against, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 379,822,268 outstanding shares: 63% for, 1% against (65% of the company cast a for/against vote).

The 137 asset managers below cast 99.4% of the shares they voted on this item FOR (237,999,169 for, 1,386,818 against).

FOR 99.4%
FOR: 237,999,169 (99.4%)AGAINST: 1,386,818 (0.6%)ABSTAIN: 1,917 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy s” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Casdin Capital, LLC76,075,6360 00For
VIKING GLOBAL INVESTORS LP58,651,1700 00For
BlackRock17,997,7920 00For
Vanguard17,413,6410 00For
Morgan Stanley12,728,5720 00For
Nikko Asset Management Co., Ltd.6,207,4590 00For
GEODE CAPITAL MANAGEMENT, LLC5,374,4380 00For
Fidelity5,110,5990 00For
Charles Schwab5,054,9410 00For
Neuberger Berman4,826,9490 00For
ARK ETF Trust3,144,1340 00For
State Street2,954,118256 00For
Equitable2,599,123315,690 00For
MAK CAPITAL ONE LLC2,845,8020 00For
Royce2,240,5030 00For
Northern Trust1,687,9770 00For
Pacific Capital Partners Ltd1,625,0000 00For
Tikvah Management LLC1,461,9470 00For
MELLON INVESTMENTS Corp1,023,7390 00For
Nuveen781,1820 00For
TIAA748,2940 00For
PRIMECAP MANAGEMENT CO/CA/594,5740 00For
AQR579,4200 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For

Showing the 25 largest of 137 asset managers. See all 137 in the interactive database.

2. TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 17,400,000 SHARES.

COMPENSATIONMajority of the votes cast: yes

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 223,394,563AGAINST: 19,589,973

STANDARD BIOTOOLS INC.’s own tally for this item (“Proposal 4: Approval of the Amendment to the Amended and Restated 2011 Equity Incentive Plan, as Amended.”): 223,394,563 for, 19,589,973 against, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 379,822,268 outstanding shares: 59% for, 5% against (64% of the company cast a for/against vote).

The 41 asset managers below cast 97% of the shares they voted on this item FOR (48,662,767 for, 1,384,038 against).

FOR 93%
FOR: 48,662,767 (93.1%)AGAINST: 1,384,038 (2.6%)ABSTAIN: 2,240,503 (4.3%)
Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NU” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,599,123315,690 00For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce00 2,240,5030Abstain
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust0245,823 00Against
Lincoln Financial0218,800 00Against
Global X177,9030 00For
AIG/SunAmerica0154,526 00Against
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock0108,174 00Against
Voya086,497 00Against
ProShares059,011 00Against
SEI49,6000 00For
Victory Capital042,622 00Against

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

3. Election of Directors: Frank Witney, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 240,269,516WITHHELD: 5,064,805

STANDARD BIOTOOLS INC.’s own tally for this item (“Elect Director: Frank Witney, Ph.D.”): 240,269,516 for, 5,064,805 withheld, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 379,822,268 outstanding shares: 63% for, 1% withheld (65% of the company cast a for/withheld vote).

The 40 asset managers below cast 100% of the shares they voted on this item FOR (52,011,800 for, 0 against).

FOR 99.4%
FOR: 52,011,800 (99.5%)ABSTAIN: 275,381 (0.5%)
Largest asset managers voting on “Election of Directors: Frank Witney, Ph.D.” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,914,8130 00For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust00 245,8230Abstain
Lincoln Financial218,8000 00For
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

4. Election of Directors: Kathy Hibbs

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 235,917,851WITHHELD: 9,416,470

STANDARD BIOTOOLS INC.’s own tally for this item (“Elect Director: Kathy Hibbs”): 235,917,851 for, 9,416,470 withheld, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 379,822,268 outstanding shares: 62% for, 2% withheld (65% of the company cast a for/withheld vote).

The 40 asset managers below cast 100% of the shares they voted on this item FOR (50,936,118 for, 0 against).

FOR 97%
FOR: 50,936,118 (97.4%)ABSTAIN: 1,351,063 (2.6%)
Largest asset managers voting on “Election of Directors: Kathy Hibbs” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,599,1230 315,6900For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA00 748,2940Abstain
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust245,8230 00For
Lincoln Financial00 218,8000Abstain
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

5. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 322,915,281AGAINST: 3,650,720

STANDARD BIOTOOLS INC.’s own tally for this item (“Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm.”): 322,915,281 for, 3,650,720 against, per its Form 8-K filed 2025-06-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 379,822,268 outstanding shares: 85% for, 1.0% against (86% of the company cast a for/against vote).

The 40 asset managers below cast 100% of the shares they voted on this item FOR (52,287,181 for, 0 against).

FOR 100%
FOR: 52,287,181 (100.0%)
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm f” at STANDARD BIOTOOLS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard16,818,1130 00For
BlackRock11,625,0000 00For
Fidelity5,097,2790 00For
ARK ETF Trust3,144,1340 00For
Equitable2,914,8130 00For
Morgan Stanley2,863,1060 00For
Charles Schwab2,527,2860 00For
Royce2,240,5030 00For
Neuberger Berman1,088,2720 00For
TIAA748,2940 00For
QUANTITATIVE MASTER SERIES LLC509,0050 00For
NEEDHAM FUNDS INC500,0000 00For
TRUST FOR PROFESSIONAL MANAGERS322,1760 00For
PRIMECAP Odyssey Funds305,8000 00For
Northern Trust245,8230 00For
Lincoln Financial218,8000 00For
Global X177,9030 00For
AIG/SunAmerica154,5260 00For
Pacific Life135,5720 00For
Bridge Builder Trust117,7980 00For
John Hancock108,1740 00For
Voya86,4970 00For
ProShares59,0110 00For
SEI49,6000 00For
Victory Capital42,6220 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

Largest STANDARD BIOTOOLS INC. shareholders voting in 2024-2025

Ranked by the number of STANDARD BIOTOOLS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 379,822,268 shares outstanding at the time of that meeting.

Top STANDARD BIOTOOLS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Casdin Capital, LLC 20.03%
2VIKING GLOBAL INVESTORS LP 15.44%
3BlackRock 4.74%
4Vanguard 4.58%
5Morgan Stanley 3.35%
6Nikko Asset Management Co., Ltd. 1.63%
7GEODE CAPITAL MANAGEMENT, LLC 1.41%
8Fidelity 1.35%
9Charles Schwab 1.33%
10Neuberger Berman 1.27%

Reported STANDARD BIOTOOLS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

STANDARD BIOTOOLS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Eli Casdin 24.71% 13D
VIKING GLOBAL INVESTORS LP 15.44% 13D
BlackRock 6.48% 13F
Vanguard Group 4.54% 13F
Morgan Stanley 2.82% 13F
Geode Capital 1.90% 13F
State Street 1.67% 13F
Millennium Management 1.34% 13F
Northern Trust 0.73% 13F
Charles Schwab 0.64% 13F

Percentages above are of 379,822,268 shares outstanding, as reported by STANDARD BIOTOOLS INC. on its Form 10-Q dated 2025-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from STANDARD BIOTOOLS INC.’s 10-Q dated 2025-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At STANDARD BIOTOOLS INC.'s shareholder meeting held 2025-06-18, in the 2024-2025 proxy season, 138 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 742 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers as disclosed… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: STANDARD BIOTOOLS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-20.

STANDARD BIOTOOLS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.